↓ Skip to main content

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

Overview of attention for article published in PLOS ONE, April 2010
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Citations

dimensions_citation
862 Dimensions

Readers on

mendeley
596 Mendeley
citeulike
5 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
Published in
PLOS ONE, April 2010
DOI 10.1371/journal.pone.0009979
Pubmed ID
Authors

Patricia Spilman, Natalia Podlutskaya, Matthew J. Hart, Jayanta Debnath, Olivia Gorostiza, Dale Bredesen, Arlan Richardson, Randy Strong, Veronica Galvan

Abstract

Reduced TOR signaling has been shown to significantly increase lifespan in a variety of organisms [1], [2], [3], [4]. It was recently demonstrated that long-term treatment with rapamycin, an inhibitor of the mTOR pathway[5], or ablation of the mTOR target p70S6K[6] extends lifespan in mice, possibly by delaying aging. Whether inhibition of the mTOR pathway would delay or prevent age-associated disease such as AD remained to be determined.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 596 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 6 1%
United States 2 <1%
Netherlands 1 <1%
Australia 1 <1%
Brazil 1 <1%
Ireland 1 <1%
India 1 <1%
Singapore 1 <1%
Iran, Islamic Republic of 1 <1%
Other 5 <1%
Unknown 576 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 137 23%
Researcher 103 17%
Student > Bachelor 83 14%
Student > Master 62 10%
Student > Doctoral Student 25 4%
Other 82 14%
Unknown 104 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 163 27%
Biochemistry, Genetics and Molecular Biology 103 17%
Neuroscience 77 13%
Medicine and Dentistry 53 9%
Pharmacology, Toxicology and Pharmaceutical Science 23 4%
Other 59 10%
Unknown 118 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 260. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2024.
All research outputs
#143,450
of 25,784,004 outputs
Outputs from PLOS ONE
#2,208
of 224,770 outputs
Outputs of similar age
#311
of 104,483 outputs
Outputs of similar age from PLOS ONE
#8
of 704 outputs
Altmetric has tracked 25,784,004 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 224,770 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,483 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 704 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.